Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pain Medicine

Gene Expression Profile Alone Is Inadequate in Predicting Complete Response in Multiple Myeloma

Leukemia

English

Early Intervention With Allogeneic Hematopoietic Cell Transplantation During Chemotherapy-Induced Aplasia in Patients With High-Risk Acute Myeloid Leukemia

English

From in Vitro to in Vivo: Intracellular Determination of Imatinib and Nilotinib May Be Related With Clinical Outcome

English

Frequent Evolution of Copy Number Alterations in CLL Following First-Line Treatment With FC(R) Is Enriched With TP53 Alterations: Results From the CLL8 Trial

English

Increased Anti-Leukemic Activity of Decitabine via AR-42-induced Upregulation of miR-29b: A Novel Epigenetic-Targeting Approach in Acute Myeloid Leukemia

English

Optimizing the Use of Lenalidomide in Relapsed or Refractory Multiple Myeloma: Consensus Statement

English

Phase I Study of the Anti Insulin-Like Growth Factor 1 Receptor (IGF-1R) Monoclonal Antibody, AVE1642, as Single Agent and in Combination With Bortezomib in Patients With Relapsed Multiple Myeloma

English

The EUTOS Prognostic Score: Review and Validation in 1288 Patients With CML Treated Frontline With Imatinib

English

Validation of Nomogram-Revised Risk Index and Comparison With Other Models for Extranodal Nasal-Type NK/T-cell Lymphoma in the Modern Chemotherapy Era: Indication for Prognostication and Clinical Decision-Making

English

Genetic Polymorphisms and Childhood Acute Lymphoblastic Leukemia: GWAS of the ESCALE Study (SFCE)

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pain Medicine

Gene Expression Profile Alone Is Inadequate in Predicting Complete Response in Multiple Myeloma

Early Intervention With Allogeneic Hematopoietic Cell Transplantation During Chemotherapy-Induced Aplasia in Patients With High-Risk Acute Myeloid Leukemia

From in Vitro to in Vivo: Intracellular Determination of Imatinib and Nilotinib May Be Related With Clinical Outcome

Frequent Evolution of Copy Number Alterations in CLL Following First-Line Treatment With FC(R) Is Enriched With TP53 Alterations: Results From the CLL8 Trial

Increased Anti-Leukemic Activity of Decitabine via AR-42-induced Upregulation of miR-29b: A Novel Epigenetic-Targeting Approach in Acute Myeloid Leukemia

Optimizing the Use of Lenalidomide in Relapsed or Refractory Multiple Myeloma: Consensus Statement

Phase I Study of the Anti Insulin-Like Growth Factor 1 Receptor (IGF-1R) Monoclonal Antibody, AVE1642, as Single Agent and in Combination With Bortezomib in Patients With Relapsed Multiple Myeloma

The EUTOS Prognostic Score: Review and Validation in 1288 Patients With CML Treated Frontline With Imatinib

Validation of Nomogram-Revised Risk Index and Comparison With Other Models for Extranodal Nasal-Type NK/T-cell Lymphoma in the Modern Chemotherapy Era: Indication for Prognostication and Clinical Decision-Making

Genetic Polymorphisms and Childhood Acute Lymphoblastic Leukemia: GWAS of the ESCALE Study (SFCE)